A
Market Data
$5.05−$0.92 (−15.41%)
ANTX · Last trade
Prev Close
$5.97
Range (30d)
$4.90 – $5.98
Recent Filings
- 1446.1 KBAN2 Therapeutics, Inc.Aug 17, 4:24 PM ET·0001972481-26-000263
- 10-Q9.3 MBAN2 Therapeutics, Inc.Aug 11, 4:04 PM ET·0001193125-26-344569
- 8-K364.6 KBAN2 Therapeutics, Inc.Aug 11, 4:01 PM ET·0001193125-26-344549
- 8-K164.2 KBAN2 Therapeutics, Inc.Jun 8, 6:23 PM ET·0001193125-26-262264
- 8-K191.6 KBAN2 Therapeutics, Inc.Jun 4, 4:15 PM ET·0001193125-26-257430
- 10-Q8.1 MBAN2 Therapeutics, Inc.May 11, 4:08 PM ET·0001193125-26-216755
- 8-K310.3 KBAN2 Therapeutics, Inc.May 11, 4:06 PM ET·0001193125-26-216752
- 8-K400.7 KBAN2 Therapeutics, Inc.Apr 9, 5:03 PM ET·0001193125-26-149822
- 8-K142.9 KBAN2 Therapeutics, Inc.Mar 20, 4:37 PM ET·0001193125-26-117765
- 10-K10.4 MBAN2 Therapeutics, Inc.Mar 17, 4:03 PM ET·0001193125-26-110693
Insiders
10- Adjuvant Capital GP, L.P.10% Owner
- Adjuvant Global Health Technology Fund DE, L.P.10% Owner
- Adjuvant Global Health Technology Fund, L.P.10% Owner
- Aziz KabeerDirector
- Chanda SanjayChief Development Officer
- Day LucyChief Financial Officer
- Easom EricDirector, Chief Executive Officer
- Eckburg PaulChief Medical Officer
- Eizen Joshua MSee Remarks
- FitzPatrick Margaret MDirector
Tickers
Addresses
business
1300 EL CAMINO REAL, SUITE 100
MENLO PARK, CA, 94025
mailing
1300 EL CAMINO REAL, SUITE 100
MENLO PARK, CA, 94025